Product code LAT— Clinical Toxicology

ORAL THC-CANNABINOIDS DIRECT RIA KIT

Classification name
Radioimmunoassay, Cannabinoid(S)
Device class
Class 2
Regulation
21 CFR 862.3870
Advisory panel
Clinical Toxicology
Total cleared
16
First cleared
Most recent

Market context for product code LAT

FDA has cleared 16 devices under product code LAT between 1978 and 2002, filed by 7 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

Top applicants under product code LAT

Recent clearances under product code LAT

Data sourced from openFDA. This site is unofficial and independent of the FDA.